Target intelligence / Profile preview

Leptospira interrogans serogroup Australis

Molecular classification
Other (Bacterial serogroup)
01

Overview

Leptospira interrogans serogroup Australis is a serogroup of pathogenic *Leptospira interrogans* strains defined by antigenic similarities in their lipopolysaccharide (LPS) structures, not a molecular target such as a receptor, enzyme, or transporter[2][4][5][6][8]. It is traditionally associated with causing leptospirosis—a zoonotic disease—in swine, dogs, and occasionally humans, typically manifesting with mild clinical signs despite infection[1][6]. Diagnosis relies mainly on serological tests targeting LPS antigens, but confusion can arise due to cross-reactivity among serogroups and serovars, making precise identification challenging[5][7]. The Australis serogroup comprises strains with genomic plasticity—meaning they can harbor variable genes due to horizontal transfer and mobile genetic elements—but there is no single molecular marker or protein that uniquely defines this group[1][6]. Antigenic and molecular classification is primarily used in epidemiological surveillance and disease control, rather than direct therapeutic targeting. Key clarifications: - This is not a molecular target (e.g., receptor, enzyme, transporter) but a group classification of bacteria based on surface antigens[2][4][6][8]. - There is no canonical abbreviation or gene/protein target associated with this entry. - The term refers to a collection of bacterial strains grouped by serological properties, not to a single molecule or therapeutic target. If you are seeking information on a specific *Leptospira interrogans* protein, enzyme, or other molecular target involved in disease, please clarify or specify the intended molecular entity.

Other names
Leptospira interrogans AustralisL. interrogans serogroup AustralisLeptospira Australis
02

Biological functions

Infectionhost colonizationpathogenicity
03

Disease associations

Infectionzoonosisleptospirosis

Beyond the preview

Go deeper on Leptospira interrogans serogroup Australis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leptospira interrogans serogroup Australis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call